MARUGAN, JUAN
National Center for Advancing Translational Sciences
USA
HTS to Identify Inhibitors of c-Abl kinase for the Potential Treatment of Alzheimers Disease
NIH (NIA)
208240.367
2
Acquired Cognitive Impairment... Aging... Alzheimer's Disease... Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)... Biotechnology... Brain Disorders... Dementia... Neurodegenerative... Neurosciences... Translational Research
During this period, the NCGC has conducted a medicinal chemistry campaign to determine the structure-activity relationships of the lead chemotypes, with a view to further improving lead potency and properties. As a center, the NCGC has fostered and maintained over 110 active collaborations with both NIH and extramural investigators, facilitating drug discovery efforts across the entire spectrum of human disease. These efforts have led to dozens of high-throughput screens and a number of medicinal chemistry campaigns to further improve on screening hits, providing our collaborators and the general research community with publications and a variety of promising small molecule probes and leads. In addition, the NCGC has worked to advance a number of informatic initiatives to make better use of existing drug and disease target information and provide the general public with easily accessible resources, further catalyzing the development of new therapies for human disease.